Hydrolytic Lysosomal Triacylglycerol-specific Enzyme [EPC] - N0000192343

Pharmacologic Class Information

Pharmacologic Code N0000192343
Pharmacologic Name Hydrolytic Lysosomal Triacylglycerol-specific Enzyme
Pharmacologic Uses
  • hydrolytic lysosomal cholesteryl ester-specific enzyme
  • hydrolytic lysosomal triacylglycerol-specific enzyme
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Hydrolytic Lysosomal Triacylglycerol-specific Enzyme

The table contains 1 products whose active ingredient are classified under the same pharmacologic class Hydrolytic Lysosomal Triacylglycerol-specific Enzyme [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
25682-007Kanuma Non-Proprietary Name: Sebelipase AlfaInjection, Solution, ConcentrateIntravenousAlexion Pharmaceuticals, Inc.ACTIVE